Hjem › Myelodysplastiske syndromer › Illinois › Springfield
Myelodysplastiske syndromer kliniske forsøg i Springfield, IL
3 studier for Myelodysplastiske syndromer søger deltagere på steder i og omkring Springfield (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Southern Illinois University School of Medicine, Springfield
Myelodysplastiske syndromer forsøg i andre byer
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- New York City, NY21 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Boston, MA19 studier
- Tampa, FL19 studier
- Miami, FL17 studier
- Columbus, OH14 studier
- Durham, NC14 studier
- Chicago, IL13 studier
- Atlanta, GA13 studier
Andre studier i Springfield
- Ikke-småcellet lungecancer13 studier
- Lungecancer12 studier
- Colorektal kræft9 studier
- Akut myeloid leukæmi8 studier
- Brystkræft8 studier
- Pladecellekræft i hoved og hals6 studier
- Nyrekancer (renocellulært karcinom)6 studier
- Prostatakræft6 studier
- Kræft (alle typer)6 studier
- Blærecancer6 studier
- Bugspytkirtelkræft5 studier
- Melanom5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.